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MSC display potent suppressive properties initially
described a decade ago. Since then, MSC suppressive
activities on T-cell effector pathways have been highly
investigated. MSC modulate CD4 cell differentiation
through different mechanisms depending on culture con-
ditions and display disparate activities on T cells according
to their differentiation status. A significant amount of evi-
dence for MSC effects on Th17 cells revealed that MSC
could be suppressive under diverse circumstances but also
enhance Th17 cell activity under other conditions. In the
present study, we investigated the suppressive effects of
MSC on Th1 and Th17 subsets of T cells using T cells
undergoing Th1 and Th17 polarization or, on mature Th1
and Th17 cells. We showed that MSC inhibited the prolif-
eration of mature Th1 cells and T cells during their differ-
entiation toward Th1 cells. This suppressive effect was
maintained in a transwell culture insert, where MSC were
plated in the insert, demonstrating the major role played
by soluble factors. Using the transwell barrier, we observed
that MSC decrease the number of T cells undergoing
Th17 differentiation whereas they did not affect IL-17 pro-
duction by mature Th17, demonstrating the need for cell
contact for suppressing Th17 cell function. We observed a
high level of PD-L1 expression on MSC co-cultured with
differentiating or polarized Th1 and Th17 cells. Impor-
tantly, using neutralizing antibodies specific for PD-L1 and
PD-1, we showed that the mechanisms by which MSC
mediate Th17 cell repolarization depend on PD-L1
expression on MSC. Taken together, our results demon-
strated a cell-to-cell contact depend mechanism in the
selective immunosuppression of MSC on mature Th17
cells through up-regulation of PD-L1.
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